• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

High fish consumption may reduce depression risk

byMichael MilliganandRavi Shah
September 23, 2015
in Chronic Disease, Psychiatry
Reading Time: 3 mins read
High fish consumption may reduce depression risk
Share on FacebookShare on Twitter

 

1. In a pooled analysis, the highest level of fish consumption was significantly associated with lower rates of depression, even in gender specific subgroup analysis.

2. The significant findings are driven mostly by studies conducted in Europe, whereas studies conducted in other continents were less likely to reveal a significant association between fish consumption and depression.

Evidence Rating Level: 2 (Good)

Study Rundown: Depression is an unfortunately common disease, representing the single largest source of disability worldwide. With an estimated 350 million people suffering from depression, and treatment that is oftentimes lacking, there is a large interest in characterizing the modifiable risk factors that could help prevent depression. Many studies have probed associations between diet and depression, with some finding that suggest increasing fish consumption may be protective against the development of depression. However, many of these findings were inconsistent and inconclusive. This study performed a meta-analysis in order to better characterize the relationship between fish consumption and the risk of depression.

This study compared the results of 26 studies that looked into the association between fish consumption and depression. The studies ranged across continents and whether they studies the effects in men, women, or both. Though this meta-analysis did not specify exact quantities of fish that were considered low or high levels, nor did it attempt to standardize the way in which depression was diagnosed, it did find in its pooled analysis that those who consumed the highest level of fish in each study were less likely to be diagnosed with depression. The meta-analysis found consistent results when analyzing all adults, just men, or just women. It also conducted subgroup analyses that showed the strongest effects of this association in Europe, while it found no significant association in studies conducted in other continents.

RELATED REPORTS

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

This study is the first meta-analysis to characterize the association between fish consumption and depression. It was limited by its inability to address possible sources of confounding within each of the studies it reviewed, as well as by inconsistencies across the studies in how consumption was quantified and how depression was diagnosed. Though it suggests that national health policies encouraging increased fish consumption could reduce the burden imposed by depression, the study was unable to comment on exact physiological mechanisms for this association and is unable to account for inconsistencies in findings by geographic region.

Click to read the study in the Journal of Epidemiology & Community Health

Relevant Reading: Omega-3 fatty acids and depression: scientific evidence and biological mechanisms

In-Depth [meta-analysis]: This meta-analysis utilized data from 26 unique studies reported in 16 journal articles to better characterize the link between fish consumption and the risk of depression. Ten of the included studies were cohort studies, while the remaining 16 were cross-sectional. In all, 150,278 participants were analyzed. Pooled analysis on adults showed that the relative risk of developing depression was 0.83 (CI95%  0.73 – 0.94) in the cohort that consumed the highest level of fish compared to the cohort with the lowest consumption.

When limiting the analysis to men, the relative risk of depression in those who consumed the most fish was of 0.80 (CI95% 0.65 – 0.99), while in women the relative risk was 0.84 (CI95% 0.77 – 0.92). Additionally, this study performed the same analysis among individual continents. Although the association between fish consumption and depression was not significant in the studies from North America, South America, and Asia, there was a significant association in Europe, where a relative risk of 0.72 (CI95% 0.63 – 0.82) was calculated. Further analysis revealed no outsize influence from any one study included in the meta-analysis on the final pooled results, as well as no significant sources of publication bias.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: depression
Previous Post

Delayed antimicrobial therapy linked with higher mortality in septic shock [Classics Series]

Next Post

Cortical volumes in African Americans with type 2 diabetes correlated with cognitive function

RelatedReports

Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Parents often unaware of adolescents’ suicidal thoughts
Psychiatry

Psychotherapy identified as most effective treatment for grief

February 2, 2026
Next Post
Diet and physical activity promotion associated with decreased risk of type 2 diabetes

Cortical volumes in African Americans with type 2 diabetes correlated with cognitive function

AAP policy addresses appropriate discharge timing for healthy term newborns

Letrozole linked to lower rate of multiple gestation and live birth vs gonadotropin: The AMIGOS study

Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients

Insertion site associated with catheter-related complications: The 3SITES study

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.